Last 164.10 INR
Change Today +5.40 / 3.40%
Volume 2.3M
SVLS On Other Exchanges
Natl India
As of 7:06 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

suven life sciences ltd (SVLS) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/28/14 - 167.00
52 Week Low
09/2/13 - 35.42
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SUVEN LIFE SCIENCES LTD (SVLS)

Related News

No related news articles were found.

suven life sciences ltd (SVLS) Related Businessweek News

No Related Businessweek News Found

suven life sciences ltd (SVLS) Details

Suven Life Sciences Limited, a research-based biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and fine chemicals for the life science industry worldwide. It provides advanced intermediates, intermediates, and active pharmaceutical ingredients. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities. In addition, it provides discovery and development of new chemical entities for CNS disorders; research collaborative projects with pharmaceutical companies; and drug discovery research services, including in-vitro screening and molecular biology, drug metabolism and pharmacokinetics, pharmacology, toxicology and genotoxicity, and bioanalysis, as well as operates a formulation development center. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. Suven Life Sciences Limited was founded in 1989 and is based in Hyderabad, India.

Founded in 1989

suven life sciences ltd (SVLS) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: 12.0M
Wholetime Director, Member of Investor Grieva...
Total Annual Compensation: 5.4M
Compensation as of Fiscal Year 2014.

suven life sciences ltd (SVLS) Key Developments

Suven Life Sciences Limited Approves Common and Special Dividend for the Year Ended March 31, 2014

Suven Life Sciences Limited at its Annual General Meeting held on August 12, 2014, approved a dividend of INR 0.50 per share (50% of face value of INR 1.00 each), with an additional special silver jubilee year dividend of INR 2.00 per share (200% of face value of INR 1.00 each), aggregating to INR 2.50 per share for the year ended March 31, 2014 on the paid up capital of the company be and is hereby declared and be paid to those beneficial owners as per the list provided by the depositories and members holding shares in physical form whose names appear on the register of members as on book closure date.

Suven Life Sciences Limited Reports Unaudited Earnings Results for First Quarter Ended June 30, 2014

Suven Life Sciences Limited reported unaudited earnings results for first quarter ended June 30, 2014. For the quarter, the company's net sales/income from operations (net of excise duty) was INR 1,415.316 million against INR 1,086.696 million a year ago. Profit from operations before income, finance cost and exceptional items was INR 554.930 million against INR 409.371 million a year ago. Profit from ordinary activities before tax was INR 513.483 million against INR 409.018 million a year ago. Net profit was INR 347.382 million or INR 2.97 basic and diluted per share before and after extraordinary items against INR 297.719 million or INR 2.55 basic and diluted per share before and after extraordinary items a year ago.

Suven Life Sciences Limited, Q1 2015 Earnings Call, Aug 13, 2014

Suven Life Sciences Limited, Q1 2015 Earnings Call, Aug 13, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVLS:IN 164.10 INR +5.40

SVLS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SVLS.
View Industry Companies

Industry Analysis


Industry Average

Valuation SVLS Industry Range
Price/Earnings 12.8x
Price/Sales 3.5x
Price/Book 7.2x
Price/Cash Flow 12.0x
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUVEN LIFE SCIENCES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at